Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Bizarre Australian mole even more unusual than first thought, new research reveals
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Collaborative research on AI safety is vital | Letters
The new vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinician
The world’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease returning, according to trial results that doctors described as “extremely impressive”.
Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.
More Stories
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict